Examining the Effects of a Mobilization With Movement and a Dynamic Stretch With Over Pressure on Hip Flexion.
Examining the Effects of a Posterolateral Mobilization With Movement (MWM) and a Dynamic Stretch With Over Pressure on Hip Flexion: A Randomized Control Trial.
The purpose of this study is to compare the effects of a mobilization with movement (MWM) technique performed by a physical therapist with those of a dynamic stretch with over pressure on active hip flexion range of motion (ROM) in those with active hip flexion ROM limitations. There is limited evidence available in the literature examining the therapeutic effects of MWM at the hip, the long term effects of MWM, or whether one modality is more effective than another. This study seeks to address these gaps in the literature by directly comparing the results of these two manual therapy interventions on active hip flexion ROM.
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Recruitment status
completed
Actual enrollment (reported)
34 participants
Study completion date
November 17, 2021
Actual (reported)
Listed locations
1 countries · 1 sites
Trial Relationships
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Related Scientific Literature
Loading related publications...
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
Degrees of change in hip flexion range of motion will be measured using a goniometer at baseline.
Degrees of hip flexion range of motion will be measured before intervention with the participant in supine .All measurements will be taken using a goniometer which measures range of motion in degrees from 0-360.
Baseline
Degrees of change in hip flexion range of motion will be measured using a goniometer immediately after intervention.
Degrees of hip flexion range of motion will be measured immediately after intervention with the participant in supine .All measurements will be taken using a goniometer which measures range of motion in degrees from 0-360.
Immediately post-intervention.
Degrees of change in hip flexion range of motion will be measured using a goniometer 24 hours after intervention.
Degrees of hip flexion range of motion will be measured 24 hours after intervention with the participant in supine. All measurements will be taken using a goniometer which measures range of motion in degrees from 0-360.
24 hours after intervention.
Degrees of change in hip flexion range of motion will be measured using a goniometer one week after intervention.
Degrees of hip flexion range of motion will be measured one week after intervention with the participant in supine. All measurements will be taken using a goniometer which measures range of motion in degrees from 0-360.
1 week after intervention.
Star Excursion Balance Test (SEBT) at baseline
The participants will perform the posterior, posterolateral, and posteromedial portions of the SEBT. The SEBT is standardized test the participant stands in the center of a mat with "stars" in 8 directions. The particpant stands on one foot and reaches with their opposite foot as far as they can without losing balance. It is method to measure functional hip flexion.
Baseline.
Star Excursion Balance Test (SEBT) immediately post-intervention
The participants will perform the posterior, posterolateral, and posteromedial portions of the SEBT. The SEBT is standardized test the participant stands in the center of a mat with "stars" in 8 directions. The particpant stands on one foot and reaches with their opposite foot as far as they can without losing balance. It is method to measure functional hip flexion.
Immediately post-intervention.
Star Excursion Balance Test (SEBT) 24 hours after intervention
The participants will perform the posterior, posterolateral, and posteromedial portions of the SEBT. The SEBT is standardized test the participant stands in the center of a mat with "stars" in 8 directions. The particpant stands on one foot and reaches with their opposite foot as far as they can without losing balance. It is method to measure functional hip flexion.
24 hours after intervention.
Star Excursion Balance Test (SEBT) one week after intervention
The participants will perform the posterior, posterolateral, and posteromedial portions of the SEBT. The SEBT is standardized test the participant stands in the center of a mat with "stars" in 8 directions. The particpant stands on one foot and reaches with their opposite foot as far as they can without losing balance. It is method to measure functional hip flexion.
1 week after intervention.
Study Arms (2)
Hip with the greatest limitation in flexion range of motion
ACTIVE COMPARATOR
Participants that have limited hip flexion of less than 101 degrees will be randomly assigned to one of two groups: one intervention group will receive Mobilization with Movement and home program of stretching with over-pressure one group will receive only a home program of stretching with over-pressure.
Procedure: Mobilization with movement and stretching, stretching or control
Hip with the least limitation in flexion range of motion
ACTIVE COMPARATOR
Participants least limited hip in flexion range of motion will serve as the control group. This limb will not receive an intervention.
Procedure: Mobilization with movement and stretching, stretching or control
Interventions
Mobilization with movement and stretching, stretching or controlProcedure
The participants will receive a therapist performed mobilization with movement and then instructed in a stretching program to be followed for one week or only receive instruction in a stretching program to be followed for one week on the hip with the greatest limitation in motion. The hip with the least amount of limitation will not receive an intervention.
Hip with the greatest limitation in flexion range of motionHip with the least limitation in flexion range of motion
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Eligibility Criteria
Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
You may not qualify if:
Any traumatic injury to or surgical procedure performed upon the lower extremities within the last six months
Any contraindication to dynamic stretching, weight-bearing rotation, or MWM of the hip joint
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Intervention Hierarchy (Ancestors)
Physiological PhenomenaMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena
Study Officials
Cathy F Arnot, DPT
University of South Carolina
PRINCIPAL INVESTIGATOR
Enrollment
34 participants (actual enrollment reported by the registry).
Study Design
Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The care provider (Cathy Arnot) will not be blinded as she knew the groups of the participants. The Investigators and the Outcomes Assessors were blinded as they were not aware of the group each participant was placed in.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A parallel design, also called a parallel group study, compares two or more treatments. Participants are randomly assigned to either group, treatments are administered, and then results are compared.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor
Study Record Dates
First Submitted
February 9, 2021
First Posted
February 21, 2021
Any dermatologic pathology in the area of the strap application
Any pain provoked by active hip flexion.
Contact the study team to confirm eligibility.
Study Start
March 9, 2021
Actual (reported)
Primary Completion
November 17, 2021
Actual (reported)
Study Completion
November 17, 2021
Actual (reported)
Last Updated
December 2, 2021
Record last verified: 2021-11
Data Sharing
IPD Sharing
Will not share
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.